<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The EMBO Journal vol.15 no.15 pp.3964-3973, 1996 <br />  <br />  <br /> RRN3 gene Saccharomyces cerevisiae encodes an <br /> essential RNA polymerase I transcription factor <br /> which interacts polymerase independently <br /> of DNA template <br /> Robert TYamamoto, Yasuhisa Nogil,                                      specialized reviews transcription Pol I, <br /> Jonathan A.Dodd Masayasu Nomura2                                   Reeder, 1992; Paule, 1994; Moss Stefanovsky, <br />                                                                        1995). SLI consists TBP (TATA binding protein) and <br /> Department Biological Chemistry, University California-Irvine,   TAFs (TBP-associated factors) (Comai et al., 1992; <br /> Irvine, CA 92717, USA &apos;Department Biochemistry,                 Eberhard et al., 1993), itself, UBF, <br /> Saitama Medical School, Moroyama, Iruma-gun, Saitama 350-04, <br /> Japan                                                                  able form stable initiation complex capable <br />                                                                        recruiting Pol I absence factors, <br /> 2Corresponding author                                                  committing template multiple cycles of <br />                                                                        transcription (Comai et al., 1992; Schnapp and <br /> RRN3 RRN genes specifically required                 Grummt, 1991). The gene UBF cloned a <br /> the transcription rDNA RNA polymerase I (Pol                     variety organisms characterized (reviewed Moss <br /> I) Saccharomyces cerevisiae. We cloned                     Stefanovsky, 1995). Although UBF DNA binding <br /> gene, determined nucleotide sequence,                    protein low sequence specificity, basis its <br /> that essential gene encodes protein                positioning exact sites promoter region is <br /> calculated molecular weight 72 369. Extracts pre-                   unclear, ability bend wrap DNA, the <br /> pared rrn3 mutants defective in vitro                     resulting structure thought help bind SLI (Bazett- <br /> transcription rDNA templates. We used extracts                      Jones et al., 1994; Copenhaver et al., 1994; Hu et al., <br /> <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> strain containing epitope-tagged Rrn3                        1994; Putnam et al., 1994). Most recently, Tjian co- <br /> protein purify factor complement                   workers succeeded cloning genes TAFs <br /> mutant extracts. Using immunoaffinity purification <br /> combined Mono Q chromatography, obtained                       human SLI, reconstituting active SLI the <br /> an essentially pure preparation Rrn3p comple-                 recombinant protein molecules (Comai et al., 1994; <br /> ments mutant extracts. By carrying template                    Zomerdijk et al., 1994). Thus, human cell <br /> commitment experiments, Rrn3p                     system, correct initiation rDNA transcription take <br /> part pre-initiation complex stable              place vitro using purified factors, UBF and <br /> multiple rounds transcription. We                   SL1, purified Pol I suitable DNA <br /> pre-incubation Rrn3p purified Pol I leads                   template. Nevertheless, possibile existence some <br /> stimulation transcription subsequent mixing                    transcription factors really excluded. Thus, <br /> with DNA template transcription reaction                     Grummt co-workers reported requirement for <br /> components. Single-round transcription experiments                     additional factors, TIF-IA TIF-IC, addition <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br /> using detergent Sarkosyl showed stimula-                 UBF SLI, initiation mouse vitro system <br /> tion increased efficiency formation                  (e.g. Schnapp Grummt, 1991). However, neither <br /> Sarkosyl-resistant pre-initiation complex. Thus, Rrn3p                 factors purified completely, their <br /> appears interact directly Pol I, apparently                    genes cloned. Because purified Pol I <br /> stimulating Pol I recruitment promoter,                  preparations used vitro experiments mam- <br /> distinct Pol I-specific transcription                   malian systems characterized, lack of <br /> factors, Rrn6/7 complex Rrn5/9/10 complex                  requirement additional factors human system <br /> (UAF), characterized previously.                                       explained presence small amounts of <br /> Keywords: rDNA transcription/RNA polymerase IIRRN3                     transcription factors purified Pol I preparations. <br /> gene/transcription factor/yeast                                        Alternatively, possibility suggested the <br />                                                                        additional factors described Grummt co-workers <br />                                                                        derived Pol I harsh <br />                                                                        conditions used purification factors (e.g. see <br /> Introduction                                                           discussion Paule, 1994). <br /> RNA polymerase I (Pol I) nuclear                      RNA polymerases Saccharomyces cerevisiae are <br /> RNA polymerases eukaryotes dedicated                      probably best characterized eukaryotic nuclear <br /> transcription rRNA genes (rDNA) nucleolus. In                RNA polymerases various sources. S.cerevisiae Pol <br /> contrast complexity Pol II initiation pathway            I (yeast Pol I) consists 14 subunits, genes all <br /> that involves array basal transcription initiation               subunits cloned characterized <br /> factors, initiation pathway Pol I generally           (Thuriaux Sentenac, 1992, references therein; <br /> thought simpler, utilizing factors              Nogi et al., 1993; Smid et al., 1995; Thuriaux et al., <br /> in metazoan vitro systems, UBF (upstream                     1995), allowing unequivocal identification other <br /> binding factor) SL 1 (promoter selectivity factor;                 factors required transcription. We used genetic <br /> also called TIF-IB) (e.g. review eukaryotic                   approach identify transcription factors specifically <br /> transcription complexes Zawel Reinberg, 1995;                   required Pol I transcription S.cerevisiae. Starting <br />  <br />   36) Oxford University Press <br /> 3964 <br />                                                                                          RRN3 encodes rDNA transcription factor <br />  <br /> from strains carrying 35S rRNA gene fused            A <br /> GAL7 promoter (pGAL7-35SrDNA) plasmid, mutants                   BamHl Spel    BstEIl    Xhol MscI                   Xbal <br /> were isolated specifically defective transcrip-                                       I <br /> tion chromosomal rDNA Pol I, growth                                                    RRN3             Jz- <br /> can rescued rRNA synthesis plasmid-                          sA <br />                                                                      YPKI <br /> encoded hybrid gene Pol II. The mutants                                 HA-, <br /> classified dozen complementation groups and <br /> the genes (RRN genes) complement mutational <br /> defects cloned characterized. Five       B <br /> genes encode subunits unique Pol I                  BamHI Spel      BstEIl        Mscl                   Xbal <br />                                                                             Il <br /> (RRN1, RRN2, RRN13, RRN12 RRN4, encoding the <br /> A190, A135, A49, A43 A12 subunits, respectively) <br /> (Nogi et al., 1991, 1993; Thuriaux et al., 1995; our <br /> unpublished experiments). Seven genes (RRN3, <br /> RRN5, RRN6, RRN7, RRN9, RRNIO RRNII) were <br /> found encode proteins correspond                                                                  1 kb <br /> of 14 subunits Pol I. In addition, extracts                                                                   -- <br />                                                                                      BamHI                BamHI <br /> strains mutations seven genes showed or <br /> greatly reduced Pol I transcription activities vitro     Fig. 1. Restriction enzyme map RRN3. (A) The BamHI-XbaI <br /> were complemented protein fractions wild-           fragment present pNOY202; (B) DNA fragment pNOY3228 <br />                                                                 used construct rrn3A::HIS3 <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span>null allele</span>. The protein <br /> type strain, i.e. seven genes appear encode proteins   coding region RRN3 stippled distal YPKI. The <br /> that function Pol I-specific transcription factors. By       position oligonucleotide encoding HAl epitope (in <br /> studying RRN6 RRN7, demonstrated pre-               pNOY333) indicated open triangle. Restriction enzyme sites <br /> viously encoded proteins, Rrn6p Rrn7p,             relevant plasmid strain constructions shown. Arrows <br />                                                                 indicate direction transcription. <br /> together protein 66 kDa (p66) form an <br /> essential transcription factor complex called Rrn6/7 <br /> complex, lacks TBP, resembles SL1 metazoan         strain (NOY675), cloned RRN3 gene comple- <br /> systems (Keys et al., 1994). More recently,             mentation. The 2.7 kb BamHI-XbaI fragment which <br /> demonstrated proteins, Rrn5p, Rrn9p              carried gene responsible complementation was <br /> RrnlOp, encoded RRN5, RRN9 RRNJO, respect-               sequenced physical structure shown Figure <br /> ively, form multiprotein transcription factor       IA. The amino acid sequence encoded protein, <br /> which contains uncharacterized protein compon-         Rrn3p, deduced nucleotide sequence shown <br /> ents. This complex (called Rrn5/9/10 complex         Figure 2A, distribution acidic basic <br /> or UAF upstream activation factor) demonstrated         amino acid residues protein shown Figure 2B. <br /> to bind directly upstream element yeast              RRN3 encodes protein 627 amino acids a <br /> rDNA promoter absence factor, forming       calculated molecular weight 72 369 calculated <br /> a stable complex able recruit Rrn6/7 complex     isoelectric point 4.4. One unique feature protein <br /> (possibly factors) committing       highly acidic region middle molecule. <br /> template transcription (Keys et al., 1996). In          This region (33 amino acids position 249 281; <br /> respect, UAF appears carry function originally       shown bold Figure 2A) contains 25 glutamic plus <br /> proposed UBF metazoan systems,            aspartic acids, significance unknown. By compar- <br /> are significant differences (Keys          ing nucleotide sequence obtained RRN3 <br /> et al., 1996). Here cloning characterization    DNA fragment sequences data bank, found <br /> of gene RRN3 encodes essential              RRN3 located left arm chromosome XI, <br /> transcription factor, distinct          499 nucleotides downstream YPKI (a protein kinase <br /> two transcription factor complexes, Rrn6/7 complex          gene; Chen et al., 1993; Figure 1A). It evident <br /> and UAF.                                                        RRN3 corresponds open reading frame called <br />                                                                 YKL125w result yeast sequencing <br /> Results                                                         project (Dujon et al., 1994). We shown, by <br />                                                                 appropriate genetic experiments, cloned gene <br /> Cloning characterization RRN3 gene                   corresponds gene originally defined rrn3 <br /> Of mutants defective transcription Pol I        mutations (our unpublished experiments). <br /> we isolated, belong complementation group          Gene disruption experiments confirmed expectation <br /> which RRN3. All rrn3 mutants isolated          <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span>phenotype</span> rrn3 mutants RRN3 an <br /> from strain carrying pGAL7-35SrDNA fusion gene          essential gene. A diploid strain (a derivative NOY397) <br /> on plasmid (pNOY103) 36&#194;&#176;C mutants             carrying disrupted rrn3 gene (rrn3A::HIS3, Figure <br /> grow galactose glucose. Synthesis RNA           LB), wild-type gene (RRN3) other <br /> in rrn3-1 mutant strain shift          chromosome, produced, sporulation, tetrads with <br /> galactose glucose medium analyzed previously,            viable non-viable spores, wild-type <br /> and severe reduction synthesis large rRNAs     HIS3 gene used disruption recovered the <br /> relative 5S tRNA synthesis demonstrated          viable spores. <br /> the mutant strain transfer galactose             We constructed haploid strain chromo- <br /> glucose medium (Nogi et al., 1991). Using mutant           somal RRN3 disrupted HIS3 carrying pGAL7- <br />  <br />                                                                                                                                  3965 <br />  R.T.Yamamoto et al. <br />  <br />                        A <br />                          1 MMAFENTSKR PPQDFVAPID QKKRKVQFSD       STGLVTLQPE     EIKDEVFSAA   MYSRFVKSAL       DDLDKNDSTQ IGIIANQVAL <br />                         81 PSKNPERIND KNLNILLDIL SSNINRIESS       RGTFLIQSII     NFEKWWELPP   HTLSKYIYFI       KILCSSIPKW WQDVSMILVS <br />                        161 CFILPIKQTV CHHDMLKYFL RMIPSSMGFI       DTYLAKFFPN     KNDTRRKLVN   YTSNLLKLRG       YCSELGFQIW SLLIEKIISI <br />                        241 DVELQNELDZ LDDDVDDDDL EEVDLEDDDD       LDDDSGDDDD     ENCGNSNEEL   RSGAADGSQS  DSEDMDIIEG MDGTEEYNVE <br />                        321 LTQGIKELST KLDSILTLVS THVEEQVTPE       SLESGEGVGV     FNTLTTLFKT   HVLPTYYTRS  IQYIMFHVSQ QQLELMDSFL <br />                        401 VTLIDISFAV NEAAEKKIKS LQYLGSYIAR       AKKLSRTQII     FVASYLTSWL   NRYVIEREEE  VDQRGGMERF KHFYAAFQAL <br />                        481 CYIFCFRHNI FRDTDGNWEC ELDKFFQRMV       ISKFNPLKFC     NENVMLMFAR    IAQQESVAYC FSIIENNNNE RLRGIIGKAD <br />                        561 SDKKENSAQA NTTSSSWSLA TRQQFIDLQS       YFPYDPLFLK     NYKILMKEYY    IEWSEASGEY ESDGSDD <br />  <br />  <br />  <br />                         B                         100       200            300      400         500           600 <br />                                            LlI   lI1 I                                        l111 I <br />                                                          I|llI I I I II I l I l111 1 1 1 11l111 <br />                                                                                              l11       1 11   111ll <br />                                       A      1     1I 1        III                     A <br />                                       B   1IIIAITII&#194;&#171;II <br />                                            oj  o l50l <br />                                                    200   I IIIii0II!iiIH <br />                                                         300    I 400I I HI {IIT1 60 1 1B <br />                                                                                               I <br />  <br />  <br />                                                   100       200            300      400         500           600 <br />  <br />  <br /> Fig. 2. (A) Predicted amino acid sequence Rm3p based nucleotide sequence. An aspartic acid-rich region shown bold. <br /> (B) Acid/<span id='am-237' about='xsp:base' typeof='owl:Thing'>base</span> map Rrn3p. Acid map: half bar, Asp; bar, Glu. Base map: small bar, His; intermediate bar, Lys; bar, Arg. <br />  <br />  <br /> 35S rDNA fusion gene plasmid. This strain (NOY604;                                      rrn3 extract                                  +   + <br /> called &apos;Arrn3&apos; strain below) grow galactose,                                   HA1-Rrn3p IPT                        2       4 <br /> not glucose, used make extracts                                            WT IPT                                   2   4 <br /> not contain Rrn3p. We constructed haploid <br /> rrn3A::HIS3 strain carrying HA1 epitope-tagged RRN3 <br /> gene centromere plasmid (pNOY333). This strain <br /> (NOY657; called &apos;HAI-RRN3&apos; strain below; Materials <br /> and methods) grew rate control strain <br /> carrying wild-type RRN3, indicating HA1-tagged <br /> Rrn3p (HA1-Rrn3p) functionally replace Rrn3p                                                                         12            3   4   5 <br /> in vivo. Extracts strain used detect                       Fig. 3. Complementation rrn3 extracts immunoaffinity- <br /> affinity purify HA1-Rrn3p monoclonal antibodies                             purified HAI-Rrn3p preparation. Transcription carried using <br /> against HAl epitope.                                                         rrn3-1 mutant extract presence 2 4 gl of <br />                                                                                  HAl-Rrn3p preparation obtained NOY657 (&apos;HA1-Rm3p IPT&apos;; <br /> Purification HA 1-Rrn3p demonstration                                  lanes 2 3), 2 4 p1 control preparation obtained from <br />                                                                                  NOY388 HAl tagging (&apos;WT IPIT&apos;; lanes 4 5) without <br /> its complementation activity using rrn3 mutant                                   addition (lane 1). An autoradiogram revealing RNA transcripts is <br /> extracts                                                                         shown. <br /> Extracts prepared HAI-RRN3 rrn3 <br /> mutant (Arrn3 rrn3-1) strains fractionated over <br /> phosphocellulose DEAE columns, yielding                             transcription (lanes 2 3), control preparation <br /> protein fractions, PC-300 (eluting phosphocellu-                      did (lanes 4 5), indicating factor comple- <br /> lose column 300 mM KCl) D-300 fraction (eluting                         menting rrn3 mutant extracts Rrn3p itself complex <br /> from DEAE column 300 mM KCl). As described                                containing Rrn3p. <br /> previously (Keys et al., 1994), accurate initiation                              The active factor purified subjecting the <br /> transcription rDNA template achieved                              affinity-purified preparation Mono Q column chromato- <br /> combination PC-300 D-300 fractions obtained                          graphy. Fractions obtained salt gradient elution were <br /> wild-type strains. Wild-type PC-300 contains Pol I                           analyzed activity complement Arrn3 extracts (Figure <br /> another unidentified factor(s) (our unpublished experi-                          4A), proteins SDS-PAGE silver staining (Figure <br /> ments), D-300 contains remaining factors                             4C) specifically Rrn3p Western blot analysis <br /> required vitro rDNA transcription assay includ-                       (Figure 4B). As expected, peak fractions containing HAl- <br /> ing Rrn6/7p complex (Keys et al., 1994), UAF (Keys                           Rrn3p complemented Arrn3 extracts; furthermore, these <br /> et al., 1996; Introduction) Rrn3p (detected                           fractions showed major protein component a <br /> SDS-PAGE followed Western blot analysis; data                             silver-stained protein band corresponded HAl- <br /> shown). Extracts rrn3 mutant strains inactive                       Rrn3p revealed Western blot. The molecular mass <br /> for specific transcription Pol I (Figure 3, lane 1). To                       calculated mobility band con- <br /> see Rrn3p fact factor deficient rrn3                         sistent calculated amino acid sequence <br /> mutant extracts, HA1-Rrn3p immunoaffinity purified                           (-73 kDa). Thus, Rrn3p does form stable multiprotein <br /> using HA 1-specific antibodies added rrn3                             complex appears function singly transcription <br /> mutant extracts, vitro transcription assays                          factor vitro system. <br /> carried out. A control preparation obtained                             In experiments, examined native molecular <br /> RRN3 strain (NOY388), does carry HAl-                              mass Rrn3p transcription factor superose 6 gel <br /> tagged RRN3, following procedure. As shown                           filtration chromatography, obtained results indicating <br /> in Figure 3, addition affinity-purified HA1-Rrn3p                         major fraction Rrn3p D-300 fraction <br /> preparation rrn3 mutant extracts showed active rDNA                           exists monomer (data shown). <br />  <br /> 3966 <br />     A <br />  <br />  <br />  <br />    B <br />  <br />  <br />  <br />    C <br />  (kD) <br />   94 - <br />  <br />   67 - <br />  <br />  <br />   43 -1 i <br />          * <br />  <br />  <br />          60 <br />              - <br />  <br />  <br />  <br />  <br />          LMW IP <br />  <br />  <br />                  .._ <br />                        IP <br />  <br />  <br />  <br />  <br />                         IP <br />                              2 <br />  <br />  <br />  <br />  <br />                              2 <br />                                  2 <br />                                      4 <br />  <br />  <br />  <br />  <br />                                      4 <br />  <br />  <br />  <br />  <br />                                      4 <br />                                          6 <br />  <br />  <br />  <br />  <br />                                          6 <br />  <br />  <br />  <br />  <br />                                          6 <br />                                              8 <br />  <br />  <br />  <br />  <br />                                              8 <br />  <br />  <br />  <br />  <br />                                              8 <br />                                                   10 12 14 16 18 20 <br />  <br />  <br />  <br />  <br />                                                   10 <br />                                                       10   12 14 16 18 20 <br />  <br />  <br />  <br />  <br />                                                            12 14 16 18 20 <br />                                                                             i-170 <br />                                                                             X-116 <br />  <br />                                                                             Vj76 <br />  <br />                                                                              -53 <br />                                                                                 (kD) <br />                                                                                  212 <br />  <br />  <br />  <br />                                                                                   * <br />                                                                                        A <br />  <br />  <br />  <br />  <br />                                                                                        B <br />                                                                                            TeI+rIa:e A <br />  <br />  <br />  <br />  <br />                                                                                              A ~ <br />                                                                                                   t   .~ ~ . <br />                                                                                                    Template A <br />                                                                                                       Template B <br />  <br />  <br />  <br />  <br />                                                                                            TempIa e 2.rrB <br />                                                                                                       - <br />                                                                                                          - <br />  <br />                                                                                                   - Hh4-Dt-- <br />  <br />  <br />  <br />  <br />                                                                                                           3 ex r c <br />                                                                                                   - HA -nrl3n <br />                                                                                                                    5 <br />                                                                                                                        HA <br />  <br />  <br />  <br />                                                                                                                        HA&apos;-RPn3p <br />  <br />  <br />  <br />  <br />                                                                                                              rr,73c xt at <br />  <br />  <br />  <br />  <br />                                                                                                                        ~ <br />                                                                                                                              A <br />                                                                                                                                  RRN3 encodes rDNA transcription factor <br />  <br />                                                                                                                                   -.- <br />                                                                                                                             r&apos;n32x~ract <br />                                                                                                                               &apos;ri3p <br />  <br />                                                                                                                                    + <br />                                                                                                                        r,n3 extrac&apos;- <br />  <br />  <br />                                                                                                                                   _ <br />  <br />  <br />                                                                                                                                       1 <br />  <br />  <br />  <br />  <br />                                                                                                                                   ~~~ of <br />                                                                                                                                            + <br />  <br />  <br />  <br />  <br />                                                                                                                                            Z <br />  <br />  <br />  <br />  <br />                                                                                                                                            M   x <br />                                                                                                                                                    2 <br />                                                                                                                                                        + <br />  <br />  <br />  <br />  <br />                                                                                                                                                            5- <br />  <br />  <br />  <br />  <br />                                                                                        Fig. 5. Rrn3p committed template-factor complex that <br />                                                                                        stable multiple rounds transcription. Two different rDNA <br />                                                                                        templates, A B, incubated separately buffer (template B <br />                                                                                        lane 2, template A lane 7), equal amounts Arrn3 <br />                                                                                        extract supplement increasing amounts affinity- <br />                                                                                        purified HAl-Rm3p templates, indicated. After a <br />                                                                                        60 min pre-incubation, extract-template mixtures were <br />                                                                                        combined new tube incubated additional 30 min (pre- <br />                                                                                        incubation 2). Transcription initiated addition nucleoside <br />                                                                                                                                                                 + <br />  <br />                                                                                                                                                                 - <br />                                                                                                                                                                 - <br />  <br />  <br />  <br />  <br />                                                                                                                                                                 6 <br />                                                                                                                                                                     - <br />  <br />  <br />  <br />  <br />                                                                                                                                                                     7 <br />                                                                                                                                                                         - <br />  <br />                                                                                                                                                                         - <br />  <br />  <br />  <br />  <br />                                                                                                                                                                         3 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                     t4TFs <br />                                                                                                                                                                             + <br />  <br />                                                                                                                                                                             + + <br />                                                                                                                                                                             - + <br />  <br />  <br />  <br />  <br />                                                                                                                                                                             .-D <br />                                                                                                                                                                                 + <br />  <br />                                                                                                                                                                                 + <br />                                                                                                                                                                                     + <br />  <br />                                                                                                                                                                                     + <br />                                                                                                                                                                                         + <br />                                                                                                                                                                                         + <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                         2 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                              Sl _p <br />  <br />  <br />  <br />  <br />                                                                                        triphosphates (NTPs). RNA products analyzed urea-PAGE. <br />   30 -1 vW                                                                             An autoradiogram shown (A) outline experiment is <br />                                                                                        shown (B). The reaction mixtures contained 0 (lane 1), 0.5, 1, 2, <br />                                                                                        4 lt (lanes 3-6 8-11) affinity-purified HAl-Rrn3p. <br />                                                                                        Lanes 2 7 contained 4 ,ul each, pre-incubation lane 12 <br />                                                                                        contained 2 ,ul HAl-Rrn3p. Lane I shows that, absence of <br />                                                                                        Rrn3p, transcription template. Lanes 2 7 <br />                                                                                        template pre-incubated (pre-incubation 1) with <br />                                                                                        Arrn3 extract (and HAl-Rrn3p) transcribed preferentially and <br /> Fig. 4. Purification Rrn3p Mono Q column chromatography.                       template pre-incubated Arrn3 extract <br /> The preparation obtained immunoaffinity purification applied                 (and HAI-Rrn3p) transcribed slightly, indicating pre- <br /> to Mono Q column, numbered fractions obtained                         incubation template extracts allows formation stable pre- <br /> elution analyzed activity complement rrn3 mutant                     initiation complex. Lane 12 positive control, showing both <br /> extract (A), HAl-Rrn3p SDS-PAGE followed Western                             templates, pre-incubated Arrn3 extract (and HAl- <br /> immunoblot analysis HAl-antibody (B). proteins                         Rrn3p), able transcribed equally. <br /> SDS-PAGE followed silver staining (C). Fraction numbers are <br /> given, IP preparation Mono Q column step. In <br /> (A), control tube addition shown ( -), (C)                UAF necessary sufficient template commitment <br /> the positions molecular weight size markers indicated left               (Keys et al., 1996). We shown previously that <br /> (lane LMW) right (lane shown). The position                      Rm6/7 complex itself fails form stable complex <br /> RNA transcript shown arrow (in A) HAl-Rrn3p <br /> is shown asterisk (in B C).                                                  template DNA, joins stable pre-initiation <br />                                                                                        complex help factor(s) [UAF possibly <br />                                                                                        factor(s)] (Keys et al., 1994). Using purified Rrn3p, <br /> Rrn3p committed template-factor                                       carried template commitment experiments and <br /> complex stable multiple rounds                                      Rrn3p does form stable complex <br /> transcription                                                                          template DNA (data shown), consistent the <br /> As shown previous studies crude yeast extracts                              conclusion UAF necessary sufficient tem- <br /> partially purified fractions (Kulkens et al., 1991; Riggs                              plate commitment. The following experiments then <br /> et al., 1995) rrn6 mutant extracts supplemented                               carried Rrn3p, like Rrn6/7 complex, <br /> with Rrn6/7 complex (Keys et al., 1994), step                            joins stable pre-initiation complex becomes <br /> of transcription rDNA vitro formation stable                             unavailable subsequently added template, according to <br /> pre-initiation complex. Protein factors bind stably                                 scheme shown Figure SB. <br /> the rDNA promoter prior formation                                     Two different templates pre-incubated separately <br /> phosphodiester bond Pol Once bound promoter, <br />                                                  l.                                    simultaneously Arrn3 extract allow initiation <br /> these factors remain bound multiple rounds                                  factors extract bind stably templates. <br /> of transcription, i.e. polymerase recruitment, initiation,                             These templates distinguished sizes of <br /> elongation, termination subsequent re-initiation. Thus,                            transcripts. To template, increasing (and sub- <br /> when excess template incubated protein                               saturating) amounts HA1-Rrn3p added. After 1 h, <br /> factors allow formation stable initiation complex,                             pre-incubating mixtures combined, incubated <br /> a second template subsequently added fails tran-                                 30 min, transcription reaction was <br /> scribed, i.e. template committed transcription.                        started addition nucleoside triphosphates. If <br /> We recently incubation purified UAF                                 Rrn3p stable pre-initiation complex, then <br /> with template forms stable complex, extracts                              template pre-incubated Rrn3p tran- <br /> which specifically deficient UAF fail so, i.e.                            scribed. If Rrn3p does bind stably complex, <br />  <br />                                                                                                                                                                                             3967 <br />  R.T.Yamamoto et al. <br />  <br />    .pol PC300                +                 +       +        +          pre-incubation, lanes). We the <br />       HAl-Rrn3p <br />     purified pol I                     +           +       +    +          degree stimulation ranged 15- 20-fold when <br />                                                                            quantitated experiments. It noted that <br />                                                                            purified Pol I preparation completely pure <br />                                                                            (see Materials methods), pre-incubation Rrn3p <br />                                                                            PC-300 Pol I-deficient mutant (APol I PC- <br />                                                                            300) did stimulation (Figure 6, lane 5 compared <br />                        1     2     3       4   5       6   7    8          lane 2), pre-incubation Rrn3p PC-300 <br />                                                                            wild-type strain gave large stimulation, as <br /> Fig. 6. Pre-incubation Rrn3p purified Pol I leads stimulation   mentioned above, indicating factor interacting <br /> of transcription. Three components, PC-300 fraction NOY446            Rrn3p absent consequence deletion of <br /> (APol I PC-300), affinity-purified HAI-Rrn3p purified Pol I <br /> (-3 tg) pre-incubated 17.5 gt buffer, individually        A135 subunit Pol I. [APol I PC-300 actually <br /> combination indicated, 60 min, supplemented               showed partial inhibition activation caused by <br /> template, Arrn3 D-300 fraction, components omitted          mixed incubation Rrn3p purified Pol I (lane 8 <br /> first incubation. After additional 30 min incubation,               compared lane 7). We think inhibition is <br /> transcription assay carried (in 40 ,l reaction mixtures).          probably non-specific, addition D-300 <br /> Because presence ammonium sulfate purified Pol I <br /> preparation used, final reaction mixtures contained 15 mM              (instead APol I PC-300) mixture Rrn3p and <br /> ammonium sulfate addition salts standard assay mixture.       purified Pol I caused partial inhibition (data not <br /> RNA products analyzed urea-PAGE. An autoradiogram               shown).] These results indicate Rrn3p interacts with <br /> shown.                                                                     purified Pol I preparation, presumably Pol I itself, <br />                                                                            leading stimulation transcription. However, attempts <br /> then Rrn3p free act templates                  demonstrate direct physical interaction Rrn3p <br /> will transcribed. The result obtained (Figure                Pol I co-immunoprecipitation sedimentation <br /> SA, lanes 3-6, 8-11; figure legend various                     analysis glycerol gradient unsuccessful <br /> control lanes). Thus, Rrn3p pre-initiation              (our unpublished experiments). Therefore, physical <br /> complex stable multiple rounds tran-                    interaction two, inferred from <br /> scription.                                                                 functional interaction, appears weak. <br />                                                                               We compared transcription non-specific DNA <br /> Rrn3p interacts purified RNA polymerase I                           template, calf thymus DNA, using Pol I without <br /> preparation                                                                pre-incubation HA1-Rrn3p. No significant stimula- <br /> In course template commitment experiments (data                     tion (or inhibition) rate non-specific transcription <br /> not shown; above), observed longer pre-                        observed pre-incubation Pol I Rrn3p, <br /> incubation Arrn3 extracts template presence                  relative control pre-incubation (data not <br /> of HAI-Rrn3p gave greater transcriptional activity                    shown). Therefore, stimulation rDNA transcription by <br /> when Rrn3p omitted added subsequently                     pre-incubation Pol I Rrn3p specific, suggesting <br /> the second short pre-incubation. We studied phenome-                  stimulation initiation step. Single- <br /> non detail. First, pre-incubation                 round transcription experiments described next <br /> Arrn3 extracts HA1-Rrn3p DNA template                      section confirm suggestion. We note that, in <br /> also, stimulates transcription (data shown). Second,                similar non-specific transcription experiments using calf <br /> found HA1-Rrn3p incubated bovine                        thymus DNA template, Killeen Greenblatt (1992) <br /> serum albumin stimulatory effect (data shown),                  showed RAP30-glutathione-S-transferase fusion <br /> suggesting stimulation result interaction              protein, glutathione-S-transferase, inhibited non- <br /> of Rrn3p component(s) extract. Since                      specific transcription Pol II. Thus, Rrn3p appears to <br /> Arrn3 extract components, PC-300                     different RAP30 subunit TFIIF this <br /> D-300 fractions, examined fractions                   respect (see Discussion). <br /> responsible pre-incubation phenomenon, found <br /> that pre-incubation Rrn3p rrn3 PC-300,                     Rrn3p required efficient transcription <br /> with rrn3 D-300, showed stimulation (data shown).                  initiation RNA polymerase I <br />    As stated earlier paper, rrn3 PC-300 contains                   The experimental data described indicate Rrn3p <br /> Pol I factor(s) required rDNA transcription                transcription factor Pol I interacts Pol I <br /> (our unpublished experiments). To Rrn3p                         prior transcription initiation, stably bound to <br /> interacting Pol I itself, experiment repeated                 committed pre-initiation complex promoter through <br /> using components pre-incubation, purified Pol                  multiple rounds transcription. However, data not <br /> I preparation (&apos;Pol I&apos;), PC-300 Pol I-deficient                     distinguish function Rrn3p required for <br /> mutant strain (NOY446) carrying disrupted rpal35 gene                    transcription initiation efficient elongation (e.g. &apos;anti- <br /> (&apos;APol I PC-300&apos;) HAI-Rrn3p. Various combinations                      pausing&apos; function). To study question, examined <br /> of components pre-incubated 1 h,                  large stimulation transcription observed with <br /> which rrn3 D-300, template omitted components                      pre-incubation Rrn3p (Pol I-containing) <br /> were added, mixtures incubated                    Arrn3 PC-300 result stimulation initiation of <br /> 30 min nucleoside triphosphates added                       transcription. Single-round transcription experiments using <br /> start transcription reaction. Activity greatly stimu-              detergent Sarkosyl carried purpose. <br /> lated pre-incubation purified Pol I HAl-                     Previous work shown suitable concentration of <br /> Rm3p (Figure 6, lane 7 compared lane 1                        Sarkosyl, added formation initiated <br /> 3968 <br />                                                                                                                                                       RRN3 encodes rDNA transcription factor <br />  <br /> A   HA1-Rrr3.z <br />        r                      PC3O       +. <br />                                                                                            NJo :--e-in:uba on <br /> APre-   C uicati~,    &apos;                                                                                                          tion completely (data shown; figure legend).] <br />                    11                                                                III                         IV              The transcription reaction allowed proceed 5.5, <br />                  - Sa roos                         -   Sark: s                  Sarko S I               -   5z.rkDvi <br />                 I.10 20         40        55             -   20   40C 55 <br />                                                                             - <br />  <br />  <br />                                                                                  0         20   40 5.5 1J              -2   42 <br />                                                                                                                                  10, 20 40 min. In absence Sarkosyl, formation <br />                                                                                                                                  transcript increased steadily 5.5 40 min, <br />                                                                                                                                  activity consistently greater pre-incubation <br />                                                                                                                                  (Figure 7A, lanes 1-4 compared 9-12). With pre- <br />             1      2     :.     4             5              7    5     5       --lI11          1           14         ,S*,      incubation, presence Sarkosyl, transcript <br />                                                                                                                                  formation leveled time 5.5 10 <br />                                                                                                                                  min (Figure 7A, lanes 5-8). This consistent what <br /> B                                                                                                                                expect single round transcription. Without <br />                                                   To m::la&apos;;-,                         ATP CTP <br />                                                                                                                                  pre-incubation Rm3p Arrn3 PC-300, transcript <br /> + - irriO3 PC3-0. - ---3pi <br />                                                   rrOn` D3CO <br />                                                   + - Lr rr3 P C330. Rri3pl <br />                                                                                        LTP - 2O.3Tp <br />                                                                                        GTP - - Sarknsy. <br />                                                                                                                                  seen faintly presence Sarkosyl (Figure <br />                                                                                                                                  7A, lanes 13-16; legend). These results strongly <br /> v                 .ncn,.m&apos;&apos;.on <br />                        60 tm;{&quot; r1s <br />                                      I                       YPre-i-cu .-,ion 2 T <br />                                                                   !,7   rfr.,        m no <br />                                                                                                              5.5-Cu <br />                                                                                                                  III <br />                                                                                                                                  suggest pre-incubation HAI-Rrn3p Pol I in <br />                                                                                                                                  Arrn3 PC-300 increased number transcription- <br /> Fig. 7. Pre-incubation Rm3p Arrn3 PC-300 increases                                                                   competent pre-initiation complexes relative reaction <br /> in vitro transcriptional efficiency assayed single-round                                                                    mixtures pre-incubation, resulting large <br /> transcription presence Sarkosyl. Affinity-purified HAI-Rrn3p                                                           difference number complete transcripts produced <br /> (20 pl) Arrn3 PC-300 (-30 ,ug protein) mixed 87.5 tl of <br /> buffer and, directly pre-incubation 60 min, added                                                         single round transcription. If Rrn3p does play <br /> buffer containing template (1 [.g) Arrn3 D-300 (-90 tg protein).                                                             role initiation transcription, i.e. reaction <br /> After 30 min incubation (pre-incubation 2), transcription                                                                 mixtures number initiation complexes at <br /> initiated addition templated nucleotides, ATP, UTP                                                         time [32P]GTP (and Sarkosyl) addition, would <br /> and GTP. After 6 min, fourth templated nucleotide, CTP, and <br /> [32P]GTP added Sarkosyl (0.025%) incubated.                                                               expect slow eventual appearance transcript <br /> Total reaction volume 200 ,ul. Equal volumes (40 pl)                                                                    absence re-initiation reaction without <br /> removed reaction stopped EDTA phenol 5.5,                                                               pre-incubation (reaction IV), case (lanes <br /> 10, 20 40 min. RNA products analyzed urea-PAGE. An                                                                   13-16; legend). This observed failure appearance <br /> autoradiogram shown (A) outline experiment                                                                significant transcript reaction <br /> shown (B). In original autoradiogram, lanes 13-16 showed faint <br /> but clear transcripts (positions indicated arrow),                                                            IV explained inadequate of <br /> clearer longer exposure. The intensity bands showed                                                             &apos;elongation-competent&apos; Pol I absence pre- <br /> the transcript increased slightly 5.5 10 min,                                                               incubation, significant transcript was <br /> remained thereafter. It noted                                                                  produced 5.5 min absence pre-incubation <br /> sequence correct transcripts starts AUGC, first <br /> three nucleotide substrates added Sarkosyl (and [32P]GTP)                                                            Rrn3p Pol I, re-initiation transcription <br /> addition experiment. In experiments,                                                                  allowed absence Sarkosyl (reaction III; <br /> nucleoside triphosphates added simultaneously Sarkosyl                                                             Figure 7A, lane 9). We note accumulation of <br /> the results obtained. In experiments, template                                                               radioactive RNA bands smears smaller sizes were <br /> Arrn3 D-300 pre-incubated separately 30 min allow                                                                    observed autoradiograms samples pre- <br /> formation stable, committed pre-initiation complex mixing <br /> with pre-incubated mixture Arrn3 PC-300 plus Rrn3p. Similar                                                                 incubation (reactions III IV) relative samples from <br /> results obtained. As stated text, addition                                                               reaction mixtures pre-incubation (reactions I II), <br /> concentration Sarkosyl time mixing pre-                                                                  expected stimulation obtained pre- <br /> incubated mixtures, Arrn3 PC-300 plus Rrn3p template plus Arrn3                                                              incubation increased efficiency elongation <br /> D-300, abolished transcription completely, indicating the <br /> concentration Sarkosyl used sufficient inhibit recruitment                                                          step (data shown). <br /> &apos;activated&apos; Pol I (or Pol I plus Rrn3p) committed pre-initiation <br /> complex consisting DNA template components D-300                                                                 Discussion <br /> (including UAF). <br />                                                                                                                                  We purified protein encoded RRN3, Rrn3p, as <br /> transcription complex, effect elongation,                                                                          epitope-tagged protein, HA1-Rm3p, demonstrated <br /> prevents re-initiation terminated polymerase,                                                                        essential transcription factor required for <br /> allowing single round transcription (Hawley                                                                        rDNA transcription Pol I vitro. This conclusion <br /> Roeder, 1987; Schnapp Grummt, 1991).                                                                                         fully confirms previous results obtained vivo <br />    As described schematically Figure 7B, mixture                                                                         experiments RRN3 gene essential gene, but <br /> HAI-Rm3p Arrn3 PC-300 (containing Pol I)                                                                                dispensable rDNA transcription achieved <br /> added Arrn3 D-300 template 1 h pre-                                                                       Pol II genetic manipulations, rrn3 mutants <br /> incubation (reactions I II) pre-incubation                                                                        specifically defective Pol I transcription under <br /> (reactions III IV). The mixtures incubated                                                                          restrictive conditions (Nogi et al., 1991). <br /> 30 min (second pre-incubation), followed addition                                                                            Our experiments strongly suggest Rrn3p part <br /> of ATP, UTP GTP allow initiation transcription,                                                                        stable pre-initiation complex and, therefore, must <br /> but extension transcripts trinucleotide                                                                        play role(s) distinct Rrn5/9/10 complex (UAF) <br /> stage (the correct transcripts start AUGC; legend                                                                       Rrn6/7 complex. It Rrn3p interacts <br /> to Figure 7). After 6 min, CTP [32P]GTP added                                                                           Pol I absence DNA template stimulates <br /> simultaneously Sarkosyl (final concentration, 0.025%;                                                                       transcription subsequent mixing rDNA tran- <br /> reactions II IV) H20 (reactions I III). [This                                                                         scription mixtures. We know stimulation <br /> concentration Sarkosyl, added start                                                                      takes place. We degree stimulation <br /> second pre-incubation, sufficient inhibit transcrip-                                                                      transcription observed pre-incubation Rrn3p with <br />  <br />                                                                                                                                                                                          3969 <br />  R.T.Yamamoto et al. <br />  <br />  purified Pol I increases time pre-incubation,       resemble Rrn3p. TIF-IC, judged activity, was <br />  reaching maximum 2-3 h incubation 22&#194;&#176;C (data         shown interact Pol I absence template <br />  shown). Thus, reaction, takes place        (Schnapp et al., 1994) apparently joins pre- <br />  pre-incubation responsible stimulation tran-      initiation complex prior binding TIF-IB <br />  scription, slow conditions used. One        (SLI), UBF Pol I (Schnapp Grummt, 1991). They <br />  possibility interaction causes conformational     shown TIF-IC required the <br />  change Pol I, increasing efficiency loading    formation Sarkosyl-resistant initiation complexes, but <br />  template-factor complex core promoter. How-          plays role elongation suppressing pausing of <br />  ever, possible &apos;activated&apos; Pol I (or Pol    Pol I, resembling Pol 1I-specific factor TFIIF (Schnapp <br />  I-Rm3p complex) higher efficiency melting          et al., 1994). As mentioned above, observed <br />  DNA template form &apos;open complex,&apos; catalyzing        evidence suppression pausing Rm3p our <br />  phosphodiester bond stimulating &apos;promoter       preliminary studies. TIF-IA identified protein that <br />  clearance.&apos; In addition, possibility        complements transcriptionally inactive extracts obtained <br />  activated Pol I higher efficiency chain elongation.    quiescent mouse cells (Schnapp et al., 1993), and <br />  Our single-round transcription experiments using            correspond factor C* studied Sollner-Webb and <br />  detergent Sarkosyl shown pre-incubation            co-workers (Brun et al., 1994). We studied the <br />  Pol I Rrn3p apparently increased           question Rrn3p plays role growth- <br />  transcription-competent pre-initiation complex, favor-     dependent regulation rDNA transcription yeast cells. <br />  ing model stimulation initiation step(s). It          Since genes TIF-IC TIF-IA (or C*) have <br />  noted Rrn3p stimulates formation pre-       cloned, compare sequence of <br />  initiation complex yet, mentioned above, does        Rrn3p Pol I transcription factors mouse <br />  remain stable pre-initiation complex. It        cells. We compared Rrn3p sequence with <br />  possible Rrn3p pre-initiation           sequences subunits TFIIF, Rap3O particular, both <br />  complex, released soon start           mammalian cells (Aso et al., 1992; Finkelstein et al., <br />  transcription (or released Pol I          1992; Sopta et al., 1989; Horikoshi et al., 1991) yeast <br />  transcription termination) utilized different         (Henry et al., 1994). No significant similarity would <br />  (competing) templates, i.e. Rrn3p complex      suggest homologous functions observed of <br />  stable multiple rounds transcription.        sequence comparisons. Thus, apparent functional <br />  This related questions current study. <br />     Rrn3p interacts Pol I absence template        similarity, e.g. Rrn3p Rap3O subunit <br />  DNA stimulates recruitment Pol I, does           mammalian TFIIF, apparent primary <br />  remain stable pre-initiation complex. In       sequences. Rap3O smaller subunit TFIIF is <br />  respects, Rrn3p appears resemble TFIIF, specifically        responsible interaction Pol II, functional <br /> the Rap3O subunit, studied metazoan Pol II transcription     resemblance bacterial 6 factors emphasized <br />  systems. It known TFIIF, consists         relation interactions core polymerases <br />  subunits, Rap3O Rap74, affinity Pol II           interaction template DNA (Sopta et al., <br />  stimulates loading Pol II promoter-factor           1989; McCracken Greenblatt, 1991; Tan et al., 1994). <br /> complexes [e.g. promoter bound TFIID (or             In fact, presence limited sequence homology <br /> TBP) TFIIB], released template      reported polymerase <br />  soon transcription initiation,       binding domains (Sopta et al., 1989; McCracken and <br /> ability reassociate Pol II elongation complex     Greenblatt, 1991) DNA binding domains (Tan et al., <br /> stalled pausing sites, presumably carrying second     1994). In connection, note Rrn3p interacts <br /> function, i.e. stimulation passage pause         vitro A49 subunit strongly A34.5 <br /> sites (Buratowski, 1994; Zawel Reinberg, 1995; Zawel        subunit weakly, yeast Pol I subunits <br /> et al., 1995). This property TFIIF, role       tested (D.Lalo, J.S.Steffan M.Nomura, unpublished <br /> elongation, appears absent Rrn3p;        experiments). Both A49 A34.5 subunits unique <br /> experiments rigorously exclude possibility        Pol I shared Pol II Pol III. If vitro <br /> such role Rrn3p, far failed observe         interactions relevant functional interaction of <br /> any indication stimulation elongation, described       Rrn3p Pol I revealed large stimulation of <br /> in Results section. In addition, mentioned       transcription activity observed pre-incubation the <br /> the Results section, carried experiments similar      two, interaction involve structure <br /> those Killeen Greenblatt (1992) examined        unique Pol I. Thus, expect similarity in <br /> the question stimulation specific transcription   primary sequence Rrn3p possible func- <br /> initiation caused pre-incubation Rrn3p Pol I      tional homologs Pol II systems. <br /> accompanied suppression non-specific initiation,         In summary, demonstrated Rrn3p Pol <br /> no evidence suppression obtained. Thus,            I-specific transcription factor; interacts Pol I, <br /> while Rrn3p resembles TFIIF, differences         causing apparent stimulation formation pre- <br /> between two.                                                initiation complex, plays essential role(s) rDNA <br />    Using mouse Pol I transcription system, Grummt         transcription. This transcription factor distinct the <br /> co-workers shown rDNA transcription requires          14 subunits Pol I yeast transcription <br /> two factors, TIF-IA TIF-IC, addition UBF, TIF-        initiation factors, UAF Rrn6/7 complex. Rrn3p <br /> IB (SL1) Pol I (Schnapp Grummit, 1991).                 purified gene available. Thus, <br /> Although TIF-IC purified, properties           future study able answer questions regarding <br />  <br /> 3970 <br />                                                                                                           RRN3 encodes rDNA transcription factor <br />  <br />  <br /> Table I. Yeast strains plasmids used <br /> Strain plasmid      Description <br />  <br /> Strains <br /> NOY388                 MATa ade2-] ura3-1 his3-11 t-pl-l leu2-3 11 c-anl-100 <br /> NOY397                 MATa/cc ade2-1/ade2-1 ura3-l/ura3-1 his3-I1/7his3-lJ trpl-l/trpl-l lelt2-3 112/ieui2-3 112 c-atl-100/canl -100 <br /> NOY446                 MAToc ade2-1 ura3-1 his3-11 tip/-I lelt2-3,112 can1l-100 rpal35A::LEU2 pNOY102 (Nogi et al.. 1991) <br /> NOY604                 MATcx ade2-1 ura3-1 his3-11 trpl-l leu2-3.112 canl-l00 rl7t3A::HIS3 pNOY103 <br /> NOY657                 MATa ade2-1 ura3-1 his3-11 trpl-l leti2-3,112 canl-100 rrn3A::HIS3 pNOY333 <br /> NOY675                 MATa ade2 ade3 leu2 ura3 trpl cali rrn3-1 pNOY103 <br /> Plasmids <br /> pRS316                E.coli-yeast shuttle vector carrying CEN6 ARSH4 URA3 (Sikorski Hieter, 1989) <br /> pNOY 102              high copy number plasmid carrying GAL7-35S rDNA, URA3, 2 p, ac1mp (Nogi et al.. 1991) <br /> pNOY103               high copy number plasmid carrying GAL7-35S rDNA, ADE3, URA3, 2 pt. amip (Nogi et cil., 1991) <br /> pNOY202               YEp351 (Hill et al., 1986) derivative 2.7 kb BamiiHI-XbaI fragment carrying RRN3 <br /> pNOY333               derivative pRS315 (CEN6 ARSH4 LEU2; Sikorski Hieter. 1989) fragment carrying HAl epitope-tagged RRN3 <br />                          inserted BamHI XbaI sites (the amino acids RRN3 coding region, MM, mutated AG) <br /> pNOY3228              pUC19 derivative fragment carrying r7n3A::HIS3 BamnHI Xbal sites <br /> pSIRT                 derivative pEMBL Ye30-A6 carries mini rDNA gene called SIRT (Musters et al.. 1989) <br /> pSIRTA+39/+ 128       derivative pSIRT (Musters et al., 1989; Kulkens et al., 1991; Materials methods) <br />  <br />  <br /> the exact function(s) Rrn3p rDNA transcription                         mutant protein encoded plasmid different Rrn3p in <br /> Pol I yeast cells.                                                           respects: amino acids MM altered AG, 11 <br />                                                                                 amino acids, MYPYDVPDYAS, added amino <br />                                                                                 acids, AG. For convenience sake, mutant hybrid gene <br /> Materials methods                                                           &apos;HA1-RRN3&apos; encoded mutant protein HAl-Rrn3p&apos;. <br />  <br /> Strains, plasmids, gene cloning genetic methods                             Transcription assays <br /> Yeast strains plasmids used study listed Table I.            In vitro reactions performed described previously (Keys et al.. <br /> Standard media genetic methods used described previously            1994). Two circular supercoiled DNA templates, pSIRT pSIRTA+39/ <br /> (Keys et al., 1994). Strain NOY675 carrying rrn3-1 <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span>mutation</span>                 + 128, used (Musters et al.. 1989; Kulkens et al., 1991). pSIRT <br /> (isolation number 416) used clone RRN3 gene comple-               carried mini-rRNA gene called SIRT, promoter <br /> mentation. The yeast genomic library based YCpNI vector                  transcription terminator regions. This template gives specific <br /> (Nakayama et al.. 1985) used purpose. DNA sequence             transcript -765 nucleotides (Keys et al., 1994). used as <br /> determined dideoxy method Tag Dye Deoxy Terminator              template A experiments described Figure 5. pSIRTA+39/+ 128 <br /> Cycle Sequencing Kit (Applied Biosystems, Foster City, CA).                     carries 90 bp deletion (and addition 15 bp derived the <br />    Strains carrying disrupted rrn3 constructed follows (see Figure      Bal31 cassette; Musters et al.. 1989; Kulkens et al., 1991) downstream <br /> 1). The 2.7 kb BamnHI-XbaI fragment present pNOY202.                   promoter, making size specific transcript -690 <br /> carries RRN3, subcloned pUC19 BamHI XbaI.                  nucleotides, used template B Figure 5. template in <br /> DNA resultant plasmid digested BstEII MscI,             experiments. &apos;Crude extracts&apos; used transcription assay <br /> 479 bp RRN3 coding region replaced 0.9 kb BamHI                consisted PC-300 fraction (4-8 pg) D-300 fraction (15-20 pg) <br /> fragment carrying HIS3 gene. Ligation carried filling         and, template (200 ng) additions, final <br /> DNA ends Klenow DNA polymerase. The resultant plasmid                      reaction volume 40 ,ul. Reactions carried 40 min at <br /> (pNOY3228) digested SpeI XbaI; fragment containing             room temperature (-22&#194;&#176;C). RNA recovered analyzed 5% <br /> the rrn3A::HIS3 transformed diploid strain (NOY397)              urea-PAGE followed autoradiography (Keys et al., 1994). For r--13 <br /> His&apos; transformants selected. One transformant (NOY597)                extracts, D-300 NOY675 (rrn3-1) (for experiment shown <br /> was confirmed tetrad analysis carry expected rr-n3A::HIS3          Figure 3) D-300 NOY604 (rrn3A::HIS3) (for other <br /> one chromosome used construct haploid strain (NOY604)              experiments) used combination PC-300 NOY604. Pol <br /> carrying rrn3A::HIS3 chromosome pGAL7-35S rDNA                   I used experiments shown Figure 6 purified according to <br /> on plasmid (pNOY103).                                                         method described previously (Riva et al.. 1982). Peak fractions obtained <br />    NOY657 carrying gene encoding HAl epitope-tagged Rrn3p                final glycerol gradient steps pooled stored -70&#194;&#176;C <br /> a plasmid (pNOY333) constructed following way. First,                experimental use. <br /> mutagenesis carried attach HAI epitope influenza <br /> virus (Wilson et al., 1984). YPYDVPDYA, amino-terminus                Purification HA 1-Rrn3p <br /> Rm3p. The 40 bp oligonucleotide, G CCT CAT ATG TAC CCA TAC                      Immunoaffinity purification HAI-Rrn3p NOY657 carried <br /> GAC GTC CCA GAC TAC GCT AGC (ATG new start codon),                       essentially previously described Rrn6/7p complex (Keys et a!., <br /> which encodes MYPYDVPDYAS, introduced immediately                  1994). Extract (-200 ml 120 g cells) mixed -5 ml of <br /> of ATG start codon RRN3 oligonucleotide-directed mutagenesis          protein G-Sepharose carrying anti-HA1 antibodies gently rolled on <br /> (Kontis Goldin, 1993). A derivative M13mpl8 carrying RRN3             roller drum 4&#194;&#176;C 2 h. Antibody beads washed twice with <br /> the entire 2672 bp BamtiHI-XbaI fragment used template,            100 ml TA300/10 buffer [TA buffer (Tris-acetate/EDTA/Mg2+ buffer <br /> 71 base oligonucleotide containing 40 nucleotide sequence             containing protease inhibitors: Keys et l., 1994) supplemented with <br /> flanked RRN3 sequences used mutagenesis primer. The new             300 mM KCI, 10% glycerol, 0.1% Tween 20]. 30 ml of <br /> BamnHI-XbaI fragment (2712 bp) subcloned BamHI-XbaI                TA300/10 buffer, twice 30 ml TA200/10 buffer (TA buffer <br /> sites pRS316, leading pNOY218. pNOY333 constructed               containing 200 mM KCI. 10% glycerol 0.1% Tween 20). Antibody <br /> by mutating amino acids original Rrn3p, Met Met,           beads mixed 5 ml TA200/10 buffer containing <br /> to Ala Gly using similar mutagenesis method. A derivative M 13mp 18        1 mg/ml HA I peptide left room temperature 30 min elute <br /> carrying template strand HAl-tagged RRN3 gene constructed            HA1-Rrn3p. Antibody beads recovered, elution step was <br /> above used template, 35 base oligonucleotide [GT ATT             repeated. Eluates combined loaded 8 ml Mono Q column <br /> CTC AAA AGC GCC GGC GCT AGC GTA GTC TGG (the opposite                           (Pharmacia) 1 ml/min. Proteins eluted linear gradient from <br /> strand GCC GGC corresponding sequence coding Ala Gly)]            TA200/10 buffer (without Tween 20) TA buffer containing 500 mM <br /> as mutagenesis primer. A derivative pRS3 16 carrying substitution     KCI 10% glycerol 15 min 1 ml/min. One ml fractions were <br /> mutation constructed above, leading pNOY333. Thus.               collected. To fraction. proteinase inhibitors added final <br />  <br />                                                                                                                                                    3971 <br />  R.T.Yamamoto et al. <br />  <br /> concentrations listed: 0.2 mM phenylmethylsulfonyl fluoride (PMSF)             Killeen,M.T. Greenblatt,J.F. (1992) The general transcription factor <br /> and 10 .g/ml pepstatin, bestatin, aprotinin, chymostatin, leupeptin       RAP30 binds RNA polymerase II prevents binding <br /> and antipain. Fractions stored -70&#194;&#176;C. For experiments shown            nonspecifically DNA. Mol. Cell. Biol., 12, 30-37. <br /> Figures 3, 5, 6 7, immunoaffinity purification small         Kontis,K.J. Goldin,A.L. (1993) Site-directed mutagenesis the <br /> scale using elution buffer TA buffer containing 200 mM                putative pore region rat IIA sodium channel. Mol. Pharmacol., <br /> potassium glutamate, 10% glycerol 1 mg/ml HAl peptide,                    43, 635-644. <br /> preparations Mono Q column chromatography used.                   Kulkens,T., Riggs,D.L., Heck,J.D., Planta,R.J. Nomura,M. (1991) <br />                                                                                   The yeast RNA polymerase I promoter: ribosomal DNA sequences <br />                                                                                   involved transcription initiation complex formation vitro. <br /> Acknowledgements                                                                  Nutcleic Acids Res., 19, 5363-5370. <br /> We thank Dr D.A.Keys initial help carrying vitro transcription   McCracken,S. Greenblatt,J. (1991) Related RNA polymerase-binding <br /> experiments Drs M.L.Waterman J.Keener reading                  regions human RAP30/74 Escherichia coli G70. Science, 253, <br /> manuscript. This work supported U.S. Public Health grant                   900-902. <br /> R37GM35949 National Institutes Health.                             Moss,T. Stefanovsky,V.Y. (1995) Promotion regulation of <br />                                                                                   ribosomal transcription eukaryotes RNA polymerase I. Prog. <br />                                                                                   Nucleic Acids. Res. Mol. Biol., 50, 25-66. <br /> References                                                                     Musters,W., Knol,J., Maas,P., Dekker,A.F., van Heerikhuizen,H. and <br />                                                                                   Planta,R.J. (1989) Linker scanning yeast RNA polymerase I <br /> Aso,T., Vasavada,H.A., Kawaguchi,T., Germino,F.J., Ganguly,S.,                    promoter. Nucleic Acids Res., 17, 9661-9678. <br />    Kitajima,S., Weissman,S.M. Yasukochi,Y. (1992) Characterization         Nakayama,N., Miyajima,A. Arai,K. (1985) Nucleotide sequences of <br />   cDNA large subunit transcription factor TFIIF.                STE2 STE3, cell type-specific sterile genes Saccharomvyces <br />   Nature, 355, 461-464.                                                           cerevisiae. EMBO J., 4, 2643-2648. <br /> Bazett-Jones,D.P., Leblanc,B., Herfort,M. Moss,T. (1994) Short-            Nogi,Y., Vu,L. Nomura,M. (1991) An approach isolation of <br />   range DNA looping Xenoplus HMG-box transcription factor,                 mutants defective 35S ribosomal RNA synthesis Saccharoin0vces <br />    xUBF. Science, 264, 1134-1137.                                                 cerevisiae. Proc. Natl Acad. Sci. USA, 88, 7026-7030. <br /> Brun,R.P., Ryan,K. Sollner-Webb,B. (1994) Factor C*, specific          Nogi,Y., Yano,R., Dodd,J., Carles,C. Nomura,M. (1993) Gene RRN4 <br />    initiation component mouse RNA polymerase I holoenzyme,              Saccharoiynvces cerevisiae encodes A 12.2 subunit RNA <br />    inactivated early transcription process. Mol. Cell. Biol., 14,          polymerase I essential high temperatures. Mol. Cell. <br />    5010-5021.                                                                     Biol., 13, 114-122. <br /> Buratowski,S. (1994) The basics basal transcription RNA                  Paule,M.R. (1994) Transcription ribosomal RNA eukaryotic RNA <br />    polymerase II. Cell, 77, 1-3.                                                  polymerase I. In Conaway,R.C. Conaway,J.W. (eds), <br /> Chen,P., Lee,K.S. Levin,D.E. (1993) A pair putative protein                Trcanscription: Mechanisms anid Regiulation. Raven Press, New York, <br />    kinase genes (YPKI YPK2) required cell growth                    pp. 83-106. <br />    Saccharo,nyces cerevisiae. Mol. Geti. Genet., 236, 443-447.                 Putnam,C.D., Copenhaver,G.P., Denton,M.L. Pikaard,C.S. (1994) <br /> Comai,L., Tanese,N. Tjian,R. (1992) The TATA-binding protein              The RNA polymerase I transactivator upstream binding factor requires <br />    associated factors integral components RNA polymerase I             dimerization domain high-mobility-group (HMG) box I to <br />    transcription factor, SL1. Cell, 68, 965-976.                                  bend, wrap, positively supercoil enhancer DNA. Mol. Cell. Biol., <br /> Comai,L., Zomerdijk,J.C.B.M., Beckmann,H., Zhou,S., Admon,A.               <br /> </body></html>